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Riley's plasma enzyme-elevating virus (1) has been shown to reduce tempo- 
rarily the rate at which infected mice clear intravenously injected carbon par- 
ticles from their blood (2, 3).  In an accompanying paper  (4) reasons axe given 
for believing that a reduced activity of the reticuloendothelial system (RES) is 
probably the major factor producing the elevated plasma enzyme levels which 
are characteristic of Riley virus-infected mice.  In support of this view it has 
been shown that intravenously injected lactate dehydrogenase (LDH) is cleared 
from the plasma at a  reduced rate in Riley virus-infected mice (2, 3), and that 
substances which alter the activity of the RES, as judged by the rate of carbon 
clearance,  affect the levels of certain plasma enzymes in  Riley virus-infected 
mice (4). The mechanism by which the activity of the RES is altered by Riley 
virus is  not clear.  The  present  study was undertaken  to  determine  whether 
agents which affect the activity of the RES alter the titre of circulating virus, 
which is a  remarkably constant feature of Riley virus infection. A preliminary 
report of this work has been published (5). 
Materials and Methods 
Animals.--Randomly bred albino mice of the Parkes strain were used. 
Test Mater/a/s.--Methods  of administration  and dosage of carbon,  zymosan,  thorotrast, 
and stilboestrol were as described previously (4). In one experiment stilboestrol was given as 
an implant:  a  15 nag tablet of stilboestrol  (implantin;  Burroughs,  Wellcome and Co., Inc., 
Tuckahoe, New York) was inserted under the skin at the back of the neck. 
Blood Samples.--Serial samples  were  obtained  by retro-orbital  (6)  or tail-bleeding,  as 
previously described (7). 
Riley Virus.--The  virus used was the same as that described in an accompanying paper 
(4). For one experiment, s partially  purified preparation  was made from the pooled plasma 
of mice infected  24 hours previously with stock Riley virus. The virus was sedimented  at 
150,000 g for 60 minutes,  and resuspended in one-tenth the volume of phosphate-buffered 
saline (dulbecco solution A) containing 0.5 per cent gelatin. The resulting preparation  had an 
infectivity titre of 10°-6m60  per ml. 
Virus Titration.--Blood samples were diluted  1 in 100 in Hanks' salt solution containing 
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0.5 per cent gelatin, blood cells removed by centrifugation, and 10-fold dilutions, based on 
the original volume of blood, prepared in the same diluent. One ml volumes were  injected 
intrapedtoneally into groups of mice which were caged individually. The test mice were bled 
after 3 days, and their plasma LDH activity estimated as described below. The number of 
mice infected at each dilution was determined, and the dose which infected 50 per cent of the 
mice (ms0) was calculated by the method of Thompson (8) and expressed on the basis of i ml 
of blood. The accuracy of the titration depends on the number of mice used. Never fewer than 
2, and in most experiments 3,  mice were  used at each dilution. In one experiment, where 
greater accuracy was required, groups of 6 mice were used. Using 2 mice at each dilution the 
standard error was about 10  °.s, with groups of 3 it was about 10  °.e, and with groups of 6 it 
was between 100.8 and 100.4  . 
Qualilative Estimation of Plasma LDH.--For estimation of plasma LDH activity, 0.05 ml 
of blood was diluted 1 in 12 with phosphate-buffered saline containing 1 international unit of 
heparin per ml, and the cells removed by ceutrifugation. Thus the plasma was diluted approxi- 
mately 1 in 24 assuming the packed cell volume to be 50 per cent. Plasma LDH activity was 
estimated by a modification of the depression plate technique described  by Kelly and Greiff 
(9). This test was performed in plastic haemagglutination trays warmed to 37°C. Into each 
depression was pipetted 0.1 ml of standard pyruvate substrate (Sigma No. 500L-l) containing 
1 mg reduced nicotinamide-adenine-dinucleotide  (C.  F. Boehringer and Soehne,  Mannheim, 
Germany) per ml. Then 0.05 ml of each plasma sample under test, diluted 1 in 24, was added 
in turn to one of the depressions  and stirred. The plasma samples were  added at  quarter 
minute intervals. The plate was incubated at 37°C, and exactly 30 minutes after adding the 
plasma to each depression  0.1 ml of colour reagent (200 mg 2:4 dinitrophenylhydrazine  and 
85 ml concentrated hydrochloric acid, diluted to 1 litre in distilled water and stored in the 
dark at +  4°C) was added. Incubation was continued for 10 minutes, and 0.2 ml 2 N sodium 
hydroxide was  then pipetted into each depression.  A  blank (phosphate-buffered saline in 
plasma) and a control plasma with LDH activity of 1500 IU per ml, were included on each 
plate. Plasma samples with an LDH activity of below 800 IU per ml give an intense brown 
colour, while those with an activity over 1200 IU per ml are colourless. By the 3rd day after 
Riley virus infection the plasma LDH activity is always over 1500 IU per ml, whereas the 
normal level is always below 800 IU per ml (10). 
RESULTS 
Viraemia in Riley Virus-Infected Mice.--The level of viraemia in 2 mice was 
determined at intervals following the intraperitoneal injection of  1  ml of the 
stock Riley virus preparation (107II~0). Titrations were performed using 3 mice 
at  each  10-fold dilution. The maximum virus titre was  attained by 24 hours 
from the time of injection, after which there was a  fairly rapid fall during the 
next 48 to  72 hours  (Fig. 1).  Subsequently the titre fell more slowly to a  rela- 
tively stable level between  105 and  10nlD~o per ml of blood.  The shape  of  the 
blood virus fitre curve (Fig. 1) suggested that the action of various substances 
on the level of viraemia could most easily be determined by measuring their 
effect on either the peak virus fitre 24 hours after infection, or on the stable level 
of viraemia 10 days or more after infection. 
Effect of Sti~nulation  or Blockade of the RES on the Levd of Viraemia 24 hours 
After Infection.--Pairs  of  male  mice  were  treated  with  stilboestrol,  carbon, 
zymosan, or thorotrast before the injection of Riley virus. The effects of these K.  E.  K.  ROWSON,  B.  W.  J'.  MAttY,  AND  M.  H.  SALAMAN  985 
treatments on RES function as measured by carbon clearance rates is described 
in a previous paper (4). Stilboestrol was given either as an implant or as a course 
of 6 daily subcutaneous injections, and the virus was injected 72 hours after the 
implant or 48 hours after the last injection.  Carbon and zymosan were given 
intravenously and thorotrast intraperitoneally at intervals before virus injection 
as shown in Table I. Two control and 2 experimental mice were injected with 
virus at the same time. Table I  shows the mean virus titres obtained 24 hours 
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FIo. 1. Virus titre in the plasma of 2 mice following the intraperitoneal injection of 10~ms0 
of Riley virus. 
after injection in the test and control mice. None of the test substances had any 
significant effect on the 24 hour virus titre in the blood. 
Effect of Stimulation or Blockade of tke RES on the Stable Level of Viraemia.-- 
Pairs of male mice which had been injected with Riley virus more than 10 days 
previously were bled before, and at intervals after, treatment with thorotrast, 
zymosan, or stilboestrol, to determine the titre of circulating virus. Virus titra- 
tions were performed using 2 mice at each 10-fold dilution. 
Thorotrast was given as a single intraperitoneal injection in a  dose of either 
1.0 ml or 0.5 ml per mouse. As shown in Fig. 2 the blood virus titre rose 24 hours 
after thorotrast administration. The small dose produced a  10-fold rise and the 
larger dose a more than 100-fold rise. In the latter case the effect lasted for at 
least 48 hours. Test substances 
Stilboestrol 
(Implant) 
(6 daily injections) 
:arbon 
~ymosan 
rhorotrast 
8- 
Interval 
between 
injections 
of test 
substances 
and virus 
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72 
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1 
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1 
18 
Expected  effect 
on  RES* 
Stimulation 
Stimulation 
Blockade 
Blockade 
Blockade 
Stimulation 
Blockade 
Blockade 
Level of viraemia 24 hrs. 
after virus injection 
(Logmm~ per ml blood) 
Control  Test 
9.5~  8.5 
8.5  8.5 
10.0  10.5 
9.0  10.0 
9.0  10.0 
10.0  9.5 
8.5  9.5 
9.5  9.5 
* See Table I in accompanying paper (4). 
Titrations performed using 2 mice at each 10-fold dilution. Values are the mean plas- 
ma vires titres of 2 mice. 
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TABLE  I 
The Effect of Various  Substances  on the Blood  Virus Ti#e g4 Hours After the Injection of 
Riley Virus 
DAYS AFTER  INJECTION  of  THOROTRAST 
FIG. 2. Mean blood virus titre in 2 pairs of mice injected intraperitoneally with either 1.0 
ml or 0.5 ml of thorotrast per mouse 10 days after infection with Riley virus. K. E. K. ROWSON,  B. W. ~'. MAHY,  AND M. H. SALAMAN  987 
Zymosan was injected intravenously into 2 mice as a single dose of 10 mg per 
100 gin body weight. Fig. 3 shows the mean blood virus titres in these mice at 
intervals after injection. Zymosan did not cause as large a rise in the mean blood 
virus titre as thorotrast, and the effect was not maintained for much more than 
24 hours. By 48 hours after injection the level of viraemia had fallen to a value 
below the starting level. 
Sfilboestrol was administered as a course of 6 daily subcutaneous injections 
of 0.1 mg in 0.1 ml of arachis oil per mouse. The effect of this course of injections 
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FIG. 3. Mean blood virus titre in 2 mice injected intravenously with zymosan (10 rag/100 
gm body weight, as a suspension in normal saline) 10 days after infection with Riley virus. 
on the mean blood virus titre is shown in Fig. 4. There was no rise in virus titre 
at 24 hours as occurred after the injection of thorotrast or zymosan. However, 
stilboestrol appeared to depress the level of viraemia slightly as did zymosan 
48 hours after injection. 
The Rate of Clearance of Riley Virus frown tke Plasrna.--It was of interest to 
know how rapidly Riley virus particles are removed from the circulation after 
injection,  and whether the rate of clearance is different in mice previously in- 
fected with the virus. It has been shown that Riley virus-infected mice clear 
carbon particles and enzymes from the blood more slowly than normal mice 
(2, 3). The clearance rate of injected Riley virus particles cannot be measured in 
uninfected mice strictly speaking, since the inoculum itself will initiate infec- 
tion. However, as no new virus particles are released into the plasma for 5 to 6 
hours after infection (11,  12) the clearance rate measured during this period in 988  MECHANISM  O1~  ACTION  OF  RILEY  VIRUS.  II 
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FIO. 4. Mean blood virus titre in 2 mice receiving a course of subcutaneous injections of 
stilboestrol. Six injections were given on days 0 to 5, each consisting of 0.1 mg stilboestrol/ 
mouse, dissolved in 0.1 ml arachis oil. 
TABLE II 
Clearance from the Plasma of Intravenously Injected Riley Virus in Pre~iously Uninfected Mice, 
and in Mice Infected uqtk Riley Virus for 3 Weeks 
Mouse No.  Previous Riley 
virus infection 
Plasma virus titre (loglom~o/ml)* 
2 minutes after  3 hours after 
virus injection  virus injection 
1  --  8.5  7.3 
2  --  8.0  7.2 
3  --  8.5  7.0 
4  --  8.5  7.0 
Mean ................................  8.4  7.2 
5  +  7.7  6.5 
6  +  8.3  6.3 
7  +  7.8  7.0 
8  +  8.5  5.9 
Mean ................................  8.2  6.2 
* Titrations performed using 6 mice at each 10-fold dilution. 
previously uninfected mice will be of injected virus only. Four uninfected  mice, 
and 4  mice infected with Riley virus 3  weeks previously, were each injected 
intravenously  with  0.1  ml  of  a  purified  virus  preparation  which  con- 
tained 10  °.qa~0 per ml of virus. The mice were bled 2 minutes and 3 hours after 
the virus injection, and the blood virus fitre determined using 6  test mice at 
each 10-fold dilution of blood. The results are given in Table II. Since the dose K. E. K. ROWSON, B. W.  J. MAltY,  AND  M. I~. SALAMAN  989 
of virus injected was large in comparison with the level of previously circulating 
virus in the infected mice it is not surprising that the blood virus titre in the two 
groups was virtually the same 2 minutes after injection. Mter 3 hours the mice 
infected 3 weeks previously had cleared rather more of the injected virus from 
their circulation than the previously uninfected mice. In fact the number of 
virus particles cleared by the previously infected mice must have been greater 
than  appeared  since  in  these  mice  new  virus  was  entering  the  circula- 
tion throughout the experiment. 
DISCUSSION 
One of the most interesting features of Riley virus infection in mice is the 
persistent viraemia. The changes in the blood virus titre following the injection 
of Riley virus shown in Fig. 1 are similar to those reported previously (11, 13, 
14) from other laboratories using different  strains of virus. 
The rapid rise in virus titre during the first 24 hours after infection  is probably 
terminated by the action of interferon, as high titres of interferon have been 
found in the plasma at this time (15). However other factors, such as the death 
of virus-producing  cells and a scarcity of further cells susceptible  to infection, 
may be involved. It seems unlikely that the RES plays any major role in limit- 
ing the peak level of viraemia, since the administration of RES blocking  or 
stimulating agents before virus injection produced no detectable change in the 
peak level of viraemia. 
It appears  likely that in the later stages  of the infection phagocytosis of 
virus particles by the RES is a factor in determining the relatively stable level 
of viraemia. In support of this, it was found that the administration of RES 
blocking or stimulating agents affected the level of viraemia in Riley virus-in- 
fected mice. That the effect of thorotrast, zymosan, and stilboestrol  on virus 
titres is mediated by the RES is supported by the close correlation observed 
between their effects on virus titres and on the rate of carbon clearance  (4). 
Thorotrast was a more active RES-blocking  agent than zymosan as judged by 
the rate of carbon clearance, and it produced a larger rise in blood virus titre. 
Zymosan blocked carbon clearance only during the first 24 hours, after which it 
stimulated clearance; and it was during the latter period, 48 hours after zymo- 
san injection, that the virus titre fell below the pretreatment level. Stilboestrol 
stimulated carbon clearance, and it produced a small but prolonged fall in virus 
titre. Similar results have been reported in two other virus infections. Blockade 
of the RES with thorotrast was found to increase the level of viraemia in mice 
infected with Semliki forest virus (16), and to decrease  the rate at which in- 
jected Newcastle disease virus disappeared from the blood of mice (17). 
Although in Riley virus-infected mice there is evidence of a reduced capa- 
bility to clear LDH and, in the first few days of infection, injected carbon par- 
tides also (2, 3), we found no evidence of reduced clearance of injected Riley 990  MECHANISM  OF ACTION OF RILEY VIRUS. II 
virus particles 21 days after infection. In fact, the short half-life of injected virus 
in both infected and previously uninfected mice suggests that the virus has a 
high turnover rate in the plasma. It is possible that such active and prolonged 
clearance of virus reduces the capacity of certain elements of the RES to clear 
some plasma enzymes, resulting in the high level of these enzymes by which 
Riley virus infection is recognised. 
The viraemic phase in many infections is terminated by the appearances of 
circulating neutralizing antibodies  (18).  However there are a  few infections, 
such as murine lymphocytic choriomeningitis (19),  equine infectious anaemia 
(20),  hog cholera (21),  and infectious hepatitis, both human (22)  and murine 
(23), in which a persistent viraemia has been described in certain circumstances. 
In Riley virus-infected mice antibodies in the plasma have not been reported, 
and in some at least of the virus infections the persistence of the viraemia de- 
pends on the failure of antibody formation. Where infection occurs before or 
soon after birth a  state of immunological paralysis may be induced. This ap- 
pears to be the mechanism involved in the case of mice neonatally  infected with 
lymphocytic choriomeningitis (24).  On the other hand, in those cases where 
mature animals are infected another explanation must be sought. It may be 
that the virus is enclosed in a non-antigenic coat, or is circulating as a free in- 
fective nucleic acid without, for some reason,  being inactivated by nuclease 
(25).  However although antibodies to Riley virus have not been reported in 
mice, they have been produced in rats (26). Assuming that the virus is antigenic 
in mice also, the failure of Riley virus-infected mice to clear their plasma of 
circulating virus by antibody formation might be explained on the theory that 
there are two types of Riley virus particle, only one of which is antigenic. In 
support of this theory evidence has recently been published that infective virus 
exists in the plasma in two forms, which differ in certain physicochemical prop- 
erties  (27,  28).  An  alternative  explanation  would  postulate  immunological 
paralysis by excess of antigen due to the very rapid replication of the virus. At 
present the evidence is not adequate to decide between the various possibilities. 
SUMMARY 
The level of viraemia was determined in serial blood samples obtained from 2 
mice after the injection of Riley virus. The plasma virus titre rose rapidly to a 
peak value of 109 to 101° I~0 per ml by 24 hours after infection, and then fell 
slowly to a level of 105 to 10~I~0 per ml by the 10th day after infection, where it 
remained relatively stable. 
Neither blockade of the RES with thorotrast, zymosan, or carbon, nor stimu- 
lation of the RES with stilboestrol or zymosan, before the injection of Riley 
virus, produced any observable alteration in the level of viraemia attained 24 
hours after infection. However 10 days or more after infection with Riley virus 
blockade of the RES with thorotrast caused a  transitory rise, and stimulation K.  E.  K.  R OWSON,  B.  W.  J.  ~AHY,  AND  xr.  H.  SALAMAN  991 
of the RES with stilboestrol caused a  slight but prolonged fall, in the level of 
viraemia. Zymosan injection at this period of infection caused an initial rise, 
followed by a  fall, in the level of viraemia; these changes correlated with the 
initial period of blockade and the subsequent period of stimulation of the RES 
observed in carbon clearance studies. 
The clearance of injected Riley virus particles from the plasma over a period 
of 3 hours after injection was measured in previously uninfected mice and mice 
which had been infected with Riley virus for 3 weeks. The mice which had been 
infected 3 weeks before the test cleared rather more of the injected virus than 
the previously uninfected mice. 
It is concluded that although the activity of the RES affects, and may de- 
termine, the level of viraemia, the permanence of the viraemia in Riley virus- 
infected mice does not appear to be due to a failure of the RES to clear virus 
particles from the plasma. 
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